Search

everythinglearnresearchcommunity

for

Search:↓

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

ASLNC168501 may help restore hair growth in androgenetic alopecia by improving hair follicle stem cell function.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Tofacitinib treatment is used for teenagers with alopecia areata.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Three compounds from Dadap leaves may help treat hair loss.

Key proteins and potential drugs for treating alopecia areata were identified.

Y-27632 helps hair follicle stem cells grow and keep their abilities.

New compounds show promise as nonsteroidal treatments for hair loss.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

L-threonate may help prevent balding by blocking a key hair loss factor.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Hes1 protein is important for hair growth and regeneration, and could be a potential treatment for hair loss.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.